Actinogen Medical (ASX:ACW) Price-to-Operating-Cash-Flow : (As of Apr. 25, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Price-to-Operating-Cash-Flow?

As of today (2024-04-25), Actinogen Medical's share price is A$0.029. Actinogen Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01. Hence, Actinogen Medical's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Actinogen Medical's Price-to-Operating-Cash-Flow or its related term are showing as below:

ASX:ACW's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.7
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Actinogen Medical's Cash Flow from Operations per share for the six months ended in Dec. 2023 was A$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -35.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.70% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 8.60% per year.

During the past 13 years, Actinogen Medical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 55.50% per year. The lowest was -54.20% per year. And the median was 15.20% per year.

Actinogen Medical Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Actinogen Medical's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Price-to-Operating-Cash-Flow Chart

Actinogen Medical Annual Data

Trend

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Actinogen Medical Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Actinogen Medical's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Actinogen Medical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Price-to-Operating-Cash-Flow falls into.

Actinogen Medical Price-to-Operating-Cash-Flow Calculation

Actinogen Medical's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.029	/	-0.006
	=

Actinogen Medical's Share Price of today is A$0.029.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Actinogen Medical's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Actinogen Medical Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical (ASX:ACW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

No Headlines